Genentech Resolves Manufacturing Filling Issues at South San Francisco Plant
This article was originally published in The Pink Sheet Daily
Genentech has resolved manufacturing filling issues at its South San Francisco manufacturing facility
You may also be interested in...
Markus Gemuend assumes the position of VP-manufacturing collaborations and contract manufacturing, overseeing the company’s manufacturing outsourcing strategies. Former ZLB Behring exec Timothy Moore recently joined Genentech as VP-corporate engineering.
Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.